You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase-specific treatment

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Approach/Avoidance Behavior Trial in Minneapolis (Transcranial magnetic stimulation (TMS))

Recruiting
  • Approach/Avoidance Behavior
  • Transcranial magnetic stimulation (TMS)
  • Minneapolis, Minnesota
    University of Minnesota
Oct 4, 2022

Development ofEORTC Immune Checkpoint Inhibitor-specific Quality

Recruiting
  • Cancer
  • +2 more
    • Paris, France
      Institut Curie
    Nov 2, 2022

    Progressive Multifocal Leukoencephalopathy Trial (CE-VST01-JC)

    Not yet recruiting
    • Progressive Multifocal Leukoencephalopathy
    • CE-VST01-JC
    • (no location specified)
    Sep 14, 2022

    Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2023

    Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))

    Recruiting
    • Solid Tumor
    • Tumor-associated antigen-specific T cell (TAA-T)
    • Washington, District of Columbia
      Children's National Hospital
    Oct 24, 2022

    Moderate COVID-19-infection Trial in Cologne (human SARS-CoV 2 specific T lymphocytes)

    Terminated
    • Moderate COVID-19-infection
    • human SARS-CoV 2 specific T lymphocytes
    • Cologne, NRW, Germany
      Department I for Internal Medicine University Hospital of Cologn
    Sep 12, 2022

    TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Ga-PSMA PET/CT
    • Brussels, Belgium
      Institut Jules Bordet
    Sep 26, 2023

    Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

    Not yet recruiting
    • Cancer
    • +3 more
    • 177Lu-PSMA-I&T - escalating renal absorbed dose
    • 177Lu-PSMA-I&T - recommended phase 2 regime
    • (no location specified)
    Jun 14, 2023

    Cytomegalovirus Infections, Solid Organ Transplant Trial in Madison (CMV specific T-cells)

    Recruiting
    • Cytomegalovirus Infections
    • Solid Organ Transplant
    • CMV specific T-cells
    • Madison, Wisconsin
      University of Wisconsin School of Medicine and Public Health
    Nov 14, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Autologous Mesothelin-specific TCR-T Cells
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 31, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023

    Respiratory Tract Infections, Infections, Allergy Trial in Geneva (Measles-Mumps-Rubella vaccine (MMR))

    Not yet recruiting
    • Respiratory Tract Infections
    • +3 more
    • Measles-Mumps-Rubella vaccine (MMR)
    • Geneva, Switzerland
      University Hospitals of Geneva
    Feb 24, 2023

    Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

    Not yet recruiting
    • Prostate Cancer
    • Darolutamide Oral Tablet [Nubeqa]
    • (no location specified)
    Jun 2, 2023

    Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

    Not yet recruiting
    • Advanced Malignancies
    • 1A46 Drug Substance
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 4, 2023

    Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)

    Recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • Patient-specific adaptive therapy
    • +2 more
    • Camperdown, New South Wales, Australia
    • +6 more
    Jan 11, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

    Recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • HER2-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Atrophy of Muscle Due to Disuse, Rehabilitation Trial in Galveston (Resistance Exercise Rehabilitation, Walking-based

    Recruiting
    • Atrophy of Muscle Due to Disuse
    • Rehabilitation
    • Resistance Exercise Rehabilitation
    • Walking-based rehabilitation
    • Galveston, Texas
      University of Texas Medical Branch
    Mar 31, 2022

    MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Stockholm, Sweden
      Department of Hematology, Karolinska University Hospital
    Mar 27, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory Trial in Memphis (drug, device, biological)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • Acute Lymphoblastic Leukemia, Refractory
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jan 3, 2023

    Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

    Recruiting
    • Lynch Syndrome
    • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
    • +2 more
    • Duarte, California
    • +3 more
    Nov 22, 2022

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    Liver Transplant Trial in Boston (biological, procedure, drug)

    Recruiting
    • Liver Transplant
    • arTreg-CSB
    • +4 more
    • Boston, Massachusetts
      Massachusetts General Hospital: Transplantation
    Jan 30, 2023

    Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

    Active, not recruiting
    • Leukemia
    • Acute Lymphoblastic Leukemia
    • gene-modified T cells targeted
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 1, 2023

    GIST Trial (Ripretinib, Sunitinib)

    Not yet recruiting
    • GIST
    • (no location specified)
    Feb 8, 2023